Finance Daily News

Displaying all results for Respiratory Disorders

Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
Dec 4, 2024
Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
Finance Daily News
Copyright © 2024 Finance Daily News.
All rights reserved.